Interestingly, Tet2 haploinsufficiency contributes to transformation in vivo, consistent with the fact that Tet2 monoallelic loss is an important pathogenic event in myeloid malignancies (Moran-Crusio et al., 2011). The gene discussed is TET2; the disease is myeloid neoplasm.